Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;68(2):391-395.
doi: 10.1016/j.amepre.2024.09.014. Epub 2024 Sep 23.

Cardiovascular Disease Mortality Trends, 2010-2022: An Update with Final Data

Affiliations

Cardiovascular Disease Mortality Trends, 2010-2022: An Update with Final Data

Rebecca C Woodruff et al. Am J Prev Med. 2025 Feb.

Abstract

Introduction: Age-adjusted mortality rates (AAMR) for cardiovascular diseases (CVD) increased in 2020 and 2021, and provisional data indicated an increase in 2022, resulting in substantial excess CVD deaths during the COVID-19 pandemic. Updated estimates using final data for 2022 are needed.

Methods: The National Vital Statistics System's final Multiple Cause of Death files were analyzed in 2024 to calculate AAMR from 2010 to 2022 and excess deaths from 2020 to 2022 for U.S. adults aged ≥35 years, with CVD as the underlying cause of death.

Results: The CVD AAMR among adults aged ≥35 years in 2022 was 434.6 deaths per 100,000 (95% CI=433.8, 435.5), which was lower than in 2021 (451.8 deaths per 100,000; 95% CI=450.9, 452.7). The most recent year with a similarly high CVD AAMR as in 2022 was 2012 (434.7 deaths per 100,000 population, 95% CI=433.8, 435.7). The CVD AAMR for 2022 calculated using provisional data overestimated the AAMR calculated using final data by 4.6% (95% CI=4.3%, 4.9%) or 19.9 (95% CI=18.6, 21.2) deaths per 100,000 population. From 2020 to 2022, an estimated 190,661 (95% CI=158,139, 223,325) excess CVD deaths occurred.

Conclusions: In 2022, the CVD AAMR among adults aged ≥35 years did not increase, but rather declined from a peak in 2021, signaling improvements in adverse mortality trends that began in 2020, amid the COVID-19 pandemic. However, the 2022 CVD AAMR remains higher than observed before the COVID-19 pandemic, indicating an ongoing need for CVD prevention, detection, and management.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests

Dr. Shah receives research support from the NHLBI (K23HL157766). No conflicts of interest were reported by other authors of this paper.

References

    1. Shah NS, Lloyd-Jones DM, O’Flaherty M, et al. Trends in cardiometabolic mortality in the United States, 1999–2017. JAMA Aug 27 2019;322(8):780–782. doi:10.1001/jama.2019.9161 - DOI - PMC - PubMed
    1. Janus SE, Makhlouf M, Chahine N, Motairek I, Al-Kindi SG. Examining disparities and excess cardiovascular mortality before and during the COVID-19 pandemic. Mayo Clin Proc Dec 2022;97(12):2206–2214. doi:10.1016/j.mayocp.2022.07.008 - DOI - PMC - PubMed
    1. Kobo O, Abramov D, Fudim M, et al. Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States? Eur Heart J Qual Care Clin Outcomes. Jun 21 2023;9(4):367–376. doi:10.1093/ehjqcco/qcac080 - DOI - PubMed
    1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics 2023 update: a report from the American Heart Association. Circulation. Feb 21 2023;147(8):e93–e621. doi:10.1161/cir.0000000000001123 - DOI - PubMed
    1. Woodruff RC, Tong X, Khan SS, et al. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022. Am J Prev Med Apr 2024;66(4):582–589. doi:10.1016/j.amepre.2023.11.009 - DOI - PMC - PubMed

LinkOut - more resources